FDA Adverse Event Injury Summary report: N

MINIMED QUICK-SET

MDR report key: 21554914 · Received March 8, 2025

Report

Report Number
3003442380-2025-03137
Event Type
Injury
Date Received
March 8, 2025
Date of Event
February 4, 2025
Report Date
May 5, 2025
Manufacturer
UNOMEDICAL UM-D
Product Code
FPA
UDI-DI
05705244017573
PMA / PMN Number
K160648
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

E1: PATIENT CITY: (B)(6), PATIENT COUNTRY: UNITED STATES.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION - THIS MDR IS BEING SUBMITTED TO INCLUDE THE BELOW: H6: INVESTIGATION RESULTS UNDER TYPE OF INVESTIGATION, INVESTIGATION FINDINGS, INVESTIGATION CONCLUSIONS H11: INVESTIGATION SUMMARY: COMPLAINT INVESTIGATION RESULTS: A COMPLAINT INVESTIGATION HAS BEEN INITIATED FOR RECORD (B)(4) ON 16-APR-2025. DEVICE HISTORY RECORD (DHR) REVIEW: THE LOT 6002837 WAS MANUFACTURED ACCORDING TO THE WORK INSTRUCTION (WI) VERSION 77 ON 27-AUG-2023, WITH A TOTAL OF (B)(4) UNITS. REVIEW OF THE DHR SHOWED THAT ALL RELEVANT TESTS REQUIRED DURING THE RELATED PROCESSES HAD BEEN FULFILLED AND MET THE REQUIREMENTS. NO DEVIATION WAS IDENTIFIED, NOR MAINTENANCE EVENTS WERE RECORDED TRENDING: A QUERY WAS RUN IN DATABASE ON 16-APR-2025 AGAINST HARM CODE NO MALFUNCTION BASED ON COMPLAINT INFORMATION, MALFUNCTION CODE NO MALFUNCTION DESCRIBE AND LOT 6002837 AND NO MORE COMPLAINT HAS BEEN REGISTERED IN DATABASE FOR THE SAME LOT, HARM CODE AND MALFUNCTION CODE. CONCLUSION SUMMARY OF COMPLAINT INVESTIGATION: AS A RESULT OF THE FOLLOWING: NO NON-CONFORMANCE (NC) RAISED DURING PRODUCTION, ONLY ONE COMPLAINT RECEIVED ON THE LOT IN QUESTION AND HARM CODE, THE TEST ON REFERENCE SAMPLES WERE NOT TESTED SINCE A NO MALFUNCTION RELATED TO THE INFUSION SET WAS REPORTED, THEREFORE NO FURTHER ACTIONS ARE REQUIRED. THIS COMPLAINT WILL NOT REQUIRE FURTHER ROOT CAUSE INVESTIGATION NOR CORRECTIVE AND PREVENTIVE ACTION (CAPA) PLAN. THEREFORE, THIS ISSUE WILL BE MONITORED THROUGH THE POST MARKET SURVEILLANCE ACTIVITIES. ROOT CAUSE OF PROBLEM: N/A - THIS COMPLAINT DID NOT REQUIRE ESCALATION TO CAPA, THEREFORE NO FURTHER ROOT CAUSE INVESTIGATION HAS BEEN COMPLETED. CORRECTIVE ACTION AS A RESULT OF THE INVESTIGATION: N/A - THIS COMPLAINT DID NOT REQUIRE ESCALATION TO CAPA, THEREFORE NO CAPA PLAN IS AVAILABLE.

Description of Event or Problem · 0

REFERENCE NUMBER (B)(4). EVENT OCCURRED IN THE UNITED STATES. IT WAS REPORTED THAT THE PATIENT EXPERIENCED HIGH BLOOD GLUCOSE LEVELS ON (B)(6) 2025. IT WAS ALSO REPORTED THAT THE PATIENT WENT TO EMERGENCY ROOM (ER) AND ADMITTED TO HOSPITAL ON (B)(6) 2025 AND RECEIVED INTRAVENOUS (IV) FLUIDS WITH INSULIN SALINE AND THE PATIENT BLOOD GLUCOSE LEVELS WHILE ADMITTING THE HOSPITAL WAS 300 MG/DL. THE PATIENT HAD SYMPTOMS OF CONFUSION, FEELING SICK/UNWELL, INCREASED THIRST, VOMITING, ABDOMINAL AND CHEST PAIN AND THE MAIN REASON FOR HOSPITALIZATION WAS HIGH BLOOD GLUCOSE LEVELS. NO FURTHER INFORMATION WAS AVAILABLE.

Description of Event or Problem · 0

TO DATE NO ADDITIONAL PATIENT OR EVENT DETAILS HAVE BEEN RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
906324 MINIMED QUICK-SET UNO QUICK-SET 60/9 SC1 MECA FPA UNOMEDICAL UM-D MMT-397A 6002837 05705244017573

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention